Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	microtubule-based movement	KIFBP ENKUR SPEF2 IFT43 ENO4 NEFL CABYR DST TTC12 VPS13A DNAH5 CFAP47 APBA1 CFAP43 WDR19 RASGRP1 CATSPER4 SSX2IP TTC21B	1.90e-06	493	223	19	GO:0007018
GeneOntologyBiologicalProcess	microtubule-based transport	KIFBP SPEF2 IFT43 NEFL CABYR DST DNAH5 APBA1 CFAP43 WDR19 RASGRP1 SSX2IP TTC21B	4.05e-06	253	223	13	GO:0099111
GeneOntologyBiologicalProcess	microtubule-based process	KIFBP ENKUR MARK1 SPEF2 SKA2 IFT43 SPDL1 ENO4 NEFL CABYR EFHC1 DST MID1IP1 TTC12 VPS13A CC2D2A DNAH5 CFAP47 WEE1 APBA1 CFAP43 WDR19 RASGRP1 CATSPER4 SSX2IP TTC21B MACF1 OCLN	1.14e-05	1058	223	28	GO:0007017
GeneOntologyCellularComponent	cilium	ENKUR SPEF2 SAXO1 IFT43 ENO4 PROM1 CABYR EFHC1 VPS13A CC2D2A DNAH5 CFAP47 MXRA8 PTPN23 CFAP43 AK8 WDR19 EFHC2 CATSPER4 KCTD10 SSX2IP PRKACB TTC21B CATSPERG	4.03e-05	898	225	24	GO:0005929
GeneOntologyCellularComponent	9+2 motile cilium	ENKUR SPEF2 SAXO1 ENO4 CABYR VPS13A DNAH5 CFAP43 AK8 CATSPER4 CATSPERG	5.72e-05	238	225	11	GO:0097729
GeneOntologyCellularComponent	intraciliary transport particle A	IFT43 WDR19 TTC21B	6.62e-05	8	225	3	GO:0030991
GeneOntologyCellularComponent	sperm principal piece	ENKUR ENO4 CABYR CATSPER4 CATSPERG	1.07e-04	44	225	5	GO:0097228
GeneOntologyCellularComponent	motile cilium	ENKUR SPEF2 SAXO1 ENO4 CABYR VPS13A DNAH5 CFAP47 CFAP43 AK8 WDR19 CATSPER4 CATSPERG	1.33e-04	355	225	13	GO:0031514
GeneOntologyCellularComponent	myosin complex	MYH6 MYH7 MYO1A MYO3A MYO18B	4.31e-04	59	225	5	GO:0016459
GeneOntologyCellularComponent	sperm flagellum	ENKUR SPEF2 SAXO1 ENO4 CABYR VPS13A AK8 CATSPER4 CATSPERG	5.38e-04	214	225	9	GO:0036126
HumanPheno	Muscle fiber cytoplasmatic inclusion bodies	MYH7 NEB GFPT1 NEFL ALG14 MYO18B	5.14e-06	32	74	6	HP:0100303
HumanPheno	Muscle fiber inclusion bodies	MYH7 NEB GFPT1 NEFL ALG14 MYO18B	1.99e-05	40	74	6	HP:0100299
Domain	KRAB	ZNF140 ZNF562 ZNF302 ZNF461 ZNF778 ZNF480 ZNF426 ZFP82 ZNF560 ZNF510 ZNF317 ZNF850 ZNF181 ZNF546 ZNF2 ZNF605 ZNF667 ZNF84	2.46e-07	358	219	18	PS50805
Domain	KRAB	ZNF140 ZNF562 ZNF302 ZNF461 ZNF778 ZNF480 ZNF426 ZFP82 ZNF560 ZNF510 ZNF317 ZNF850 ZNF181 ZNF546 ZNF2 ZNF605 ZNF667 ZNF84	2.46e-07	358	219	18	PF01352
Domain	KRAB	ZNF140 ZNF562 ZNF302 ZNF461 ZNF778 ZNF480 ZNF426 ZFP82 ZNF560 ZNF510 ZNF317 ZNF850 ZNF181 ZNF546 ZNF2 ZNF605 ZNF667 ZNF84	3.84e-07	369	219	18	SM00349
Domain	KRAB	ZNF140 ZNF562 ZNF302 ZNF461 ZNF778 ZNF480 ZNF426 ZFP82 ZNF560 ZNF510 ZNF317 ZNF850 ZNF181 ZNF546 ZNF2 ZNF605 ZNF667 ZNF84	4.00e-07	370	219	18	IPR001909
Domain	zf-C2H2_6	ZNF140 ZNF562 ZNF302 ZNF461 ZNF778 ZNF480 ZNF426 ZFP82 ZNF560 ZNF317 ZNF850 ZNF181 ZNF546 ZNF605 ZNF667 ZNF84	9.84e-07	314	219	16	PF13912
Domain	TPR-contain_dom	GTF3C3 TTC19 TTC12 VPS13A TTC28 PTPN23 WDR19 TMTC1 TTC21B LONRF2	1.12e-05	150	219	10	IPR013026
Domain	TPR_REGION	GTF3C3 TTC19 TTC12 VPS13A TTC28 PTPN23 WDR19 TMTC1 TTC21B LONRF2	2.57e-05	165	219	10	PS50293
Domain	TPR	GTF3C3 TTC19 TTC12 VPS13A TTC28 PTPN23 WDR19 TMTC1 TTC21B LONRF2	2.57e-05	165	219	10	PS50005
Domain	-	KIFBP CLTCL1 ST7L GTF3C3 TTC19 TTC12 TTC28 WDR19 TMTC1 TTC21B LONRF2	3.44e-05	207	219	11	1.25.40.10
Domain	Myosin_head_motor_dom	MYH6 MYH7 MYO1A MYO3A MYO18B	7.76e-05	38	219	5	IPR001609
Domain	MYOSIN_MOTOR	MYH6 MYH7 MYO1A MYO3A MYO18B	7.76e-05	38	219	5	PS51456
Domain	Myosin_head	MYH6 MYH7 MYO1A MYO3A MYO18B	7.76e-05	38	219	5	PF00063
Domain	MYSc	MYH6 MYH7 MYO1A MYO3A MYO18B	7.76e-05	38	219	5	SM00242
Domain	TPR-like_helical_dom	KIFBP CLTCL1 ST7L GTF3C3 TTC19 TTC12 TTC28 WDR19 TMTC1 TTC21B LONRF2	1.00e-04	233	219	11	IPR011990
Domain	DUF1712	CCZ1B CCZ1	1.37e-04	2	219	2	PF08217
Domain	DUF1712_fun	CCZ1B CCZ1	1.37e-04	2	219	2	IPR013176
Domain	TPR_2	GTF3C3 TTC19 TTC12 TTC28 TMTC1	2.92e-04	50	219	5	PF07719
Domain	TPR_2	GTF3C3 TTC19 TTC12 TTC28 TMTC1	2.92e-04	50	219	5	IPR013105
Domain	TPR_8	GTF3C3 TTC12 TTC28 TMTC1 TTC21B	3.84e-04	53	219	5	PF13181
Domain	DUF1126	EFHC1 EFHC2	4.07e-04	3	219	2	IPR010554
Domain	DUF1126	EFHC1 EFHC2	4.07e-04	3	219	2	PF06565
Domain	DM10	EFHC1 EFHC2	4.07e-04	3	219	2	SM00676
Domain	DM10	EFHC1 EFHC2	4.07e-04	3	219	2	PS51336
Domain	Uncharacterised_DM10	EFHC1 EFHC2	4.07e-04	3	219	2	IPR006602
Domain	P-loop_NTPase	MYH6 MYH7 MYO1A VWA8 ABCA13 SPEF2 RUVBL2 MYO3A SULT1B1 HS6ST1 IFI44L MYO18B GNAZ DNAH5 AK8 RAD50 MTIF2 CARD11 CTPS1 SNRNP200 ATP5F1A TDRD12	4.23e-04	848	219	22	IPR027417
Domain	IQ_motif_EF-hand-BS	MYH6 MYH7 ENKUR MYO1A MYO3A MYO18B	6.66e-04	90	219	6	IPR000048
Domain	Kinase-like_dom	RAPH1 MARK1 PBK RIOK3 CHUK MYO3A DST ALPK3 KDR MAP3K15 CAMK1D WEE1 PRKACB MACF1 ATM DCLK1	6.87e-04	542	219	16	IPR011009
Domain	IQ	MYH6 MYH7 ENKUR MYO1A MYO3A MYO18B	7.92e-04	93	219	6	PS50096
Domain	TEX28/TMCC	TMCC2 TMCC1	8.09e-04	4	219	2	IPR019394
Domain	Tmemb_cc2	TMCC2 TMCC1	8.09e-04	4	219	2	PF10267
Domain	TPR	GTF3C3 TTC19 TTC12 TTC28 TMTC1 TTC21B LONRF2	8.26e-04	129	219	7	SM00028
Domain	TPR_repeat	GTF3C3 TTC19 TTC12 TTC28 TMTC1 TTC21B LONRF2	9.89e-04	133	219	7	IPR019734
Domain	-	ZNF140 ZNF562 ZNF302 ZNF461 ZNF778 ZNF480 ZNF426 ZFP82 ZNF560 ZNF510 ZNF317 ZNF850 ZNF181 ZNF546 ZNF2 ZNF605 ZNF667 ZNF84	1.11e-03	679	219	18	3.30.160.60
Domain	Myosin-like_IQ_dom	MYH6 MYH7 MYO18B	1.34e-03	19	219	3	IPR027401
Domain	-	MYH6 MYH7 MYO18B	1.34e-03	19	219	3	4.10.270.10
Domain	zf-C2H2	ZNF140 ZNF562 ZNF302 ZNF461 ZNF778 ZNF480 ZNF426 ZFP82 ZNF560 ZNF510 ZNF317 ZNF850 ZNF181 ZNF546 ZNF2 ZNF605 ZNF667 ZNF84	1.40e-03	693	219	18	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	ZNF140 ZNF562 ZNF302 ZNF461 ZNF778 ZNF480 ZNF426 ZFP82 ZNF560 ZNF510 ZNF317 ZNF850 ZNF181 ZNF546 ZNF2 ZNF605 ZNF667 ZNF84	1.42e-03	694	219	18	IPR013087
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MYH6 MYH7 CLTCL1 MYO1A RAPH1 SPEF2 NEB PLA2G4D CHUK NEFL DST STXBP2 ZNF608 VPS13A CC2D2A KDR ALDH1B1 PPIP5K2 MCF2L TASOR MNDA IMMT PLXNA3 PARP8 GRIA1 PRPF8 PABPC3 PRKACB MACF1 UGGT2 ZNF84 ATM ATP5F1A DOP1A	1.07e-10	1442	228	34	35575683
Pubmed	A biological consequence of variation in the site of D-JH gene rearrangement.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.80e-09	4	228	4	6434992
Pubmed	Mouse monoclonal antibodies to pneumococcal C-polysaccharide backbone show restricted usage of VH-DH-JH gene segments and share the same kappa chain.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.80e-09	4	228	4	19428559
Pubmed	An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH, D and JH.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.80e-09	4	228	4	6769593
Pubmed	Crossreactive B cells are present during a primary but not secondary response in BALB/c mice expressing a bcl-2 transgene.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.80e-09	4	228	4	10449099
Pubmed	Specific H chain junctional diversity may be required for non-T15 antibodies to bind phosphorylcholine.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.80e-09	4	228	4	3135325
Pubmed	Clonal Progression during the T Cell-Dependent B Cell Antibody Response Depends on the Immunoglobulin DH Gene Segment Repertoire.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.80e-09	4	228	4	25157256
Pubmed	Structure of the T15 VH gene subfamily: identification of immunoglobulin gene promotor homologies.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.80e-09	4	228	4	3108392
Pubmed	The D segment defines the T15 idiotype: the immunoresponse of A/J mice to Pneumococcus pneumoniae.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.80e-09	4	228	4	6499907
Pubmed	Significant structural and functional change of an antigen-binding site by a distant amino acid substitution: proposal of a structural mechanism.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.80e-09	4	228	4	2748602
Pubmed	Antibody diversity: somatic hypermutation of rearranged VH genes.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.80e-09	4	228	4	6101208
Pubmed	Developmentally controlled expression of immunoglobulin VH genes.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.80e-09	4	228	4	3975629
Pubmed	An immunoglobulin promoter region is unaltered by DNA rearrangement and somatic mutation during B-cell development.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.80e-09	4	228	4	6296789
Pubmed	Immunoglobulin heavy chain gene organization in mice: analysis of a myeloma genomic clone containing variable and alpha constant regions.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.80e-09	4	228	4	106394
Pubmed	Somatic evolution of diversity among anti-phosphocholine antibodies induced with Proteus morganii.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.80e-09	4	228	4	3106498
Pubmed	Idiotype-specific Th cells support oligoclonal expansion of anti-dsDNA B cells in mice with lupus.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.80e-09	4	228	4	25127856
Pubmed	Oligodendrocyte-reactive O1, O4, and HNK-1 monoclonal antibodies are encoded by germline immunoglobulin genes.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.80e-09	4	228	4	8750831
Pubmed	Defective secretion of an immunoglobulin caused by mutations in the heavy chain complementarity determining region 2.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.80e-09	4	228	4	8046334
Pubmed	Size differences among immunoglobulin heavy chains from phosphorylcholine-binding proteins.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.80e-09	4	228	4	819932
Pubmed	Somatic hypermutation of an immunoglobulin transgene in kappa transgenic mice.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.80e-09	4	228	4	3104790
Pubmed	A V region mutation in a phosphocholine-binding monoclonal antibody results in loss of antigen binding.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.80e-09	4	228	4	2005389
Pubmed	Repertoire shift in the humoral response to phosphocholine-keyhole limpet hemocyanin: VH somatic mutation in germinal center B cells impairs T15 Ig function.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.80e-09	4	228	4	12734355
Pubmed	Characterization of gene use and efficacy of mouse monoclonal antibodies to Streptococcus pneumoniae serotype 8.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.80e-09	4	228	4	21068211
Pubmed	Sequence and fine specificity analysis of primary 511 anti-phosphorylcholine antibodies.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	1.80e-09	4	228	4	2512348
Pubmed	IgD+IgM- B cells mount immune responses that exhibit altered antibody repertoire.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	8.95e-09	5	228	4	14991595
Pubmed	Increased junctional diversity in fetal B cells results in a loss of protective anti-phosphorylcholine antibodies in adult mice.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	8.95e-09	5	228	4	10367906
Pubmed	An intrinsic propensity of murine peritoneal B1b cells to switch to IgA in presence of TGF-β and retinoic acid.	IGHV3-73 IGHV3-72 IGHV3-49 IGHV3-15	8.95e-09	5	228	4	24324757
Pubmed	Abrogation of the Cripto gene in mouse leads to failure of postgastrulation morphogenesis and lack of differentiation of cardiomyocytes.	MYH6 MYH7 HAND1 KDR HAND2	9.26e-08	18	228	5	9876177
Pubmed	Dual function of the UNC-45b chaperone with myosin and GATA4 in cardiac development.	MYH6 MYH7 HAND1 HAND2	1.23e-07	8	228	4	22553207
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	ABCA13 SPEF2 CEP95 VPS13A DNAH5 AFF2 DOCK10 RAD50 CARD11 DOP1A TDRD12	1.47e-07	208	228	11	33230847
Pubmed	Emergence of the ZNF91 Krüppel-associated box-containing zinc finger gene family in the last common ancestor of anthropoidea.	ZNF778 ZNF426 ZFP82 ZNF317 ZNF850	1.66e-07	20	228	5	7479878
Pubmed	Activation of the c-H-ras proto-oncogene by retrovirus insertion and chromosomal rearrangement in a Moloney leukemia virus-induced T-cell leukemia.	ZNF778 ZNF426 ZFP82 ZNF317 ZNF850	1.66e-07	20	228	5	2542606
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MARK1 PTDSS1 TMCC2 PUM3 TASOR PCDH18 DOCK2 PTPN23 ANO8 UTP4 SSX2IP TTC21B MACF1 SNRNP200 TMCC1 DOP1A	1.98e-07	493	228	16	15368895
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	VWA8 PBK ADAR SUPT6H GOLIM4 VPS51 IMMT HAT1 PRPF8 RAD50 UTP4 NUP133 NUP93 OCLN CTPS1 SNRNP200 ATP5F1A	2.10e-07	560	228	17	35241646
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	MYO1A VWA8 MARK1 SUPT6H USP4 IMMT USP47 NEDD4L TTC28 OTUD5 TAF1A APBA2 HAT1 PRPF8 RAD50 SSU72 ATP6AP2 KCTD10 SSX2IP UGGT2 NUP93 LONRF2 SNRNP200	2.38e-07	1005	228	23	19615732
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	KIFBP NAP1L1 ADAR RUVBL2 GFPT1 STXBP2 PUM3 DNAH5 HAT1 PTPN23 VTA1 PRPF8 RAD50 SSU72 UTP4 NUP133 CTPS1 SNRNP200 ATP5F1A	2.43e-07	704	228	19	29955894
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	MAX NAP1L1 RIOK3 ADAR RUVBL2 GFPT1 GTF3C3 DST PUM3 TAF2 ALDH1B1 IMMT GOLGA4 DOCK10 PTPN23 VTA1 PRPF8 RAD50 TGM1 UTP4 NUP133 MACF1 AKAP10 NUP93 CTPS1 SNRNP200 ATP5F1A	3.09e-07	1353	228	27	29467282
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	ABCA13 MARK1 NAP1L1 NEB RUVBL2 CHUK GREB1L DST IMMT FAT4 TTC28 HAT1 ATP6AP2 TTC21B SNRNP200 ATP5F1A	3.37e-07	513	228	16	25798074
Pubmed	Suppression of atrial myosin gene expression occurs independently in the left and right ventricles of the developing mouse heart.	MYH6 MYH7 HAND1 HAND2	3.66e-07	10	228	4	10679931
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	NR2C2 KIFBP VWA8 PTDSS1 NCLN GTF3C3 ADCY9 DMXL1 SUPT6H VPS13A IMMT GOLGA4 PRPF8 WDR19 ATP6AP2 MTIF2 UTP4 SSX2IP PRKACB TMEM209 NUP133 MACF1 UGGT2 ATM OCLN SMCR8 SNRNP200 TMCC1	5.84e-07	1487	228	28	33957083
Pubmed	Jumonji, a nuclear protein that is necessary for normal heart development.	MYH6 MYH7 HAND1 HAND2	8.55e-07	12	228	4	10807864
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	MYH6 MARK1 PTDSS1 NAP1L1 NEFL DST USP4 ALDH1B1 GNAZ VPS51 IMMT IGHV3-73 IGHV3-72 IGHV3-49 SGIP1 NEDD4L IGHV3-15 GRIA1 CRMP1 TGM1 PABPC3 KCTD10 MACF1 RAPGEF2 SNRNP200 DCLK1 ATP5F1A	9.10e-07	1431	228	27	37142655
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	GTF3C3 ADCY9 DMXL1 DST VPS13A TASOR GOLGA4 FAT4 AFF2 TTC28 RUFY1 AK8 FRMD6 RAPGEF2 OCLN CLSPN SMCR8 SNRNP200 ATP5F1A	1.06e-06	777	228	19	35844135
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	NAP1L1 ZNF302 GFPT1 CHUK NEFL DST IMMT USP47 TTC28 APBA1 APBA2 PRPF8 ZNF181 CRMP1 WDR19 ZNF605 MTIF2 MACF1 ZNF84 ATM RAPGEF2 SNRNP200 DCLK1 ATP5F1A ECE2	1.38e-06	1285	228	25	35914814
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	NAP1L1 GFPT1 GTF3C3 NEFL DST SUPT6H PUM3 IMMT USP47 PRPF8 RAD50 UTP4 NUP133 MACF1 ATM NUP93 SNRNP200	1.73e-06	653	228	17	22586326
Pubmed	Genetic analysis of specific and redundant roles for p38alpha and p38beta MAPKs during mouse development.	MYH6 MYH7 HAND1 HAND2 MEF2B	2.02e-06	32	228	5	21768366
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	KIFBP NAP1L1 NCLN ADAR RUVBL2 GFPT1 GTF3C3 SPDL1 SUPT6H CC2D2A PUM3 ALDH1B1 MYO18B DNAH5 IMMT GOLGA4 HAT1 PRPF8 RAD50 UTP4 NUP133 ATM NUP93 CTPS1 SNRNP200 ATP5F1A	2.71e-06	1425	228	26	30948266
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	RAPH1 NAP1L1 RUVBL2 GFPT1 STXBP2 CEP95 TAF2 ALDH1B1 PPIP5K2 USP47 TTC28 PTPN23 RUFY1 RAD50 MEIOC SSX2IP PRKACB TMEM209 NUP93	4.12e-06	853	228	19	28718761
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	RAPH1 DLC1 DST CEP95 PPIP5K2 ABTB2 GOLGA4 NEDD4L TTC28 WEE1 PARP8 FRMD6 SSX2IP MACF1 NUP93 RAPGEF2 TMCC1 DCLK1 DOP1A	4.70e-06	861	228	19	36931259
Pubmed	Foxh1 is essential for development of the anterior heart field.	MYH6 HAND1 HAND2 MEF2B	5.12e-06	18	228	4	15363409
Pubmed	Proper coronary vascular development and heart morphogenesis depend on interaction of GATA-4 with FOG cofactors.	HAND1 KDR HAND2	5.48e-06	6	228	3	11297508
Pubmed	Ciliopathy-associated mutations of IFT122 impair ciliary protein trafficking but not ciliogenesis.	IFT43 WDR19 TTC21B	5.48e-06	6	228	3	29220510
Pubmed	Role for the IFT-A Complex in Selective Transport to the Primary Cilium.	IFT43 WDR19 TTC21B	5.48e-06	6	228	3	27806291
Pubmed	Analysis of the Hand1 cell lineage reveals novel contributions to cardiovascular, neural crest, extra-embryonic, and lateral mesoderm derivatives.	HAND1 KDR HAND2	5.48e-06	6	228	3	20882677
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	MYH7 NAP1L1 RIOK3 ZNF302 NEB TTC19 DST SUPT6H PUM3 MYO18B ZNF426 ZNF181 NUP133 MACF1	5.99e-06	497	228	14	23414517
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	KIFBP VWA8 NT5C3A NCLN ADCY9 TTC19 NEFL DST VPS13A ALDH1B1 IMMT PGBD5 USP47 TTC28 VTA1 TRUB2 MTRF1 ATP6AP2 MTIF2 UTP4 SSX2IP TMEM209 NUP133 SMCR8 TMCC1 ATP5F1A	6.44e-06	1496	228	26	32877691
Pubmed	Congenital heart disease-causing Gata4 mutation displays functional deficits in vivo.	MYH6 MYH7 HAND1 HAND2	6.45e-06	19	228	4	22589735
Pubmed	Bmp signaling regulates myocardial differentiation from cardiac progenitors through a MicroRNA-mediated mechanism.	MYH6 MYH7 HAND1 HAND2	8.03e-06	20	228	4	21145505
Pubmed	Novel roles of cardiac-derived erythropoietin in cardiac development and function.	MYH6 MYH7 KDR	9.55e-06	7	228	3	38382296
Pubmed	Intraflagellar transport-A complex mediates ciliary entry and retrograde trafficking of ciliary G protein-coupled receptors.	IFT43 WDR19 TTC21B	9.55e-06	7	228	3	27932497
Pubmed	The long noncoding RNA Charme supervises cardiomyocyte maturation by controlling cell differentiation programs in the developing heart.	MYH6 MYH7 SPDL1 MYO18B	1.20e-05	22	228	4	36877136
Pubmed	Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis.	MYH6 HAND1 KDR HAND2	1.20e-05	22	228	4	9136933
Pubmed	Morphogenesis of the right ventricle requires myocardial expression of Gata4.	MYH6 MYH7 HAND1 HAND2	1.44e-05	23	228	4	15902305
Pubmed	Ablation of the CLP-1 gene leads to down-regulation of the HAND1 gene and abnormality of the left ventricle of the heart and fetal death.	MYH7 HAND1 HAND2	1.52e-05	8	228	3	15172687
Pubmed	The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development.	MYH6 MYH7 HAND1 HAND2	1.72e-05	24	228	4	10021345
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	RAPH1 NAP1L1 ADAR RUVBL2 GTF3C3 SPDL1 TAF2 TTC28 PTPN23 RUFY1 RAD50 MTRF1 CTPS1 SNRNP200	1.82e-05	549	228	14	38280479
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	ADCY9 DST ZNF608 TMCC2 TTC28 DOCK10 PTPN23 MACF1 SNRNP200	1.94e-05	225	228	9	12168954
Pubmed	GATA6 is essential for embryonic development of the liver but dispensable for early heart formation.	MYH6 MYH7 HAND1 HAND2	2.04e-05	25	228	4	15767668
Pubmed	TULP3 bridges the IFT-A complex and membrane phosphoinositides to promote trafficking of G protein-coupled receptors into primary cilia.	IFT43 WDR19 TTC21B	2.27e-05	9	228	3	20889716
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	NR2C2 RAPH1 GTF3C3 SPDL1 GREB1L DST MID1IP1 ZNF608 TASOR TTC28 RUFY1 RAD50	2.32e-05	418	228	12	34709266
Pubmed	APC controls asymmetric Wnt/β-catenin signaling and cardiomyocyte proliferation gradient in the heart.	MYH6 MYH7 HAND1 HAND2	2.40e-05	26	228	4	26493106
Pubmed	Cardiomyopathy in Irx4-deficient mice is preceded by abnormal ventricular gene expression.	MYH6 MYH7 HAND1 HAND2	2.40e-05	26	228	4	11238910
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	NEB ADAR DST KDR DNAH5 PRPF8 RAD50 MACF1 SNRNP200	2.65e-05	234	228	9	36243803
Pubmed	Acetylation-Mimic Mutation of TRIM28-Lys304 to Gln Attenuates the Interaction with KRAB-Zinc-Finger Proteins and Affects Gene Expression in Leukemic K562 Cells.	ZNF140 ZNF562 ZNF778 ZNF480 ZFP82 ZNF317 ZNF181 ZNF84	2.79e-05	181	228	8	37372979
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	RAPH1 NAP1L1 RUVBL2 GFPT1 DST PPIP5K2 NEDD4L HAT1 PTPN23 PRPF8 RAD50 MACF1 CTPS1	2.86e-05	498	228	13	36634849
Pubmed	NF-kappaB activation in T cells requires discrete control of IkappaB kinase alpha/beta (IKKalpha/beta) phosphorylation and IKKgamma ubiquitination by the ADAP adapter protein.	NR2C2 CHUK CARD11	3.23e-05	10	228	3	20164171
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	COG3 DMXL1 DST VPS13A DIAPH2 ATG9A IMMT GOLGA4 CCZ1B ATP6AP2 TMEM209 OCLN SMCR8	3.23e-05	504	228	13	34432599
Pubmed	Tbx20 is essential for cardiac chamber differentiation and repression of Tbx2.	MYH6 MYH7 HAND1 HAND2	3.26e-05	28	228	4	15901664
Pubmed	Cardiac Med1 deletion promotes early lethality, cardiac remodeling, and transcriptional reprogramming.	MYH6 MYH7 CKMT2 ATP5F1A	3.26e-05	28	228	4	28159809
Pubmed	Reversible epigenetic modifications of the two cardiac myosin heavy chain genes during changes in expression.	MYH6 MYH7	4.28e-05	2	228	2	21526716
Pubmed	Macrophage receptors for influenza A virus: role of the macrophage galactose-type lectin and mannose receptor in viral entry.	CLEC10A MRC1	4.28e-05	2	228	2	20106926
Pubmed	Expression dynamics of HAND1/2 in in vitro human cardiomyocyte differentiation.	HAND1 HAND2	4.28e-05	2	228	2	34297940
Pubmed	The macrophage galactose-type lectin can function as an attachment and entry receptor for influenza virus.	CLEC10A MRC1	4.28e-05	2	228	2	24257596
Pubmed	Interaction between p230 and MACF1 is associated with transport of a glycosyl phosphatidyl inositol-anchored protein from the Golgi to the cell periphery.	GOLGA4 MACF1	4.28e-05	2	228	2	15265687
Pubmed	Human endothelin converting enzyme-2 (ECE2): characterization of mRNA species and chromosomal localization.	EEF1AKMT4-ECE2 ECE2	4.28e-05	2	228	2	11718899
Pubmed	Acf7 (MACF) is an actin and microtubule linker protein whose expression predominates in neural, muscle, and lung development.	DST MACF1	4.28e-05	2	228	2	11002341
Pubmed	Characterization of human cardiac myosin heavy chain genes.	MYH6 MYH7	4.28e-05	2	228	2	2726733
Pubmed	Epilepsy-associated gene Nedd4-2 mediates neuronal activity and seizure susceptibility through AMPA receptors.	NEDD4L GRIA1	4.28e-05	2	228	2	28212375
Pubmed	Human cardiac myosin heavy chain genes and their linkage in the genome.	MYH6 MYH7	4.28e-05	2	228	2	3037493
Pubmed	β-myosin heavy chain is induced by pressure overload in a minor subpopulation of smaller mouse cardiac myocytes.	MYH6 MYH7	4.28e-05	2	228	2	21778428
Pubmed	Structural organization of the human cardiac alpha-myosin heavy chain gene (MYH6).	MYH6 MYH7	4.28e-05	2	228	2	8307559
Pubmed	HAND proteins: molecular mediators of cardiac development and congenital heart disease.	HAND1 HAND2	4.28e-05	2	228	2	10189962
Pubmed	Molecular cloning and characterization of human cardiac alpha- and beta-form myosin heavy chain complementary DNA clones. Regulation of expression during development and pressure overload in human atrium.	MYH6 MYH7	4.28e-05	2	228	2	2969919
Pubmed	A role for Mints in transmitter release: Mint 1 knockout mice exhibit impaired GABAergic synaptic transmission.	APBA1 APBA2	4.28e-05	2	228	2	12547917
Pubmed	Biallelic mutations of TTC12 and TTC21B were identified in Chinese patients with multisystem ciliopathy syndromes.	TTC12 TTC21B	4.28e-05	2	228	2	36273201
Pubmed	Gene in the region of the Friedreich ataxia locus encodes a putative transmembrane protein expressed in the nervous system.	APBA1 APBA2	4.28e-05	2	228	2	7678331
Pubmed	Nedd4-2 interacts with occludin to inhibit tight junction formation and enhance paracellular conductance in collecting duct epithelia.	NEDD4L OCLN	4.28e-05	2	228	2	20504882
Pubmed	Distribution and structure-function relationship of myosin heavy chain isoforms in the adult mouse heart.	MYH6 MYH7	4.28e-05	2	228	2	17575272
Pubmed	Prenatal alcohol exposure causes the over-expression of DHAND and EHAND by increasing histone H3K14 acetylation in C57 BL/6 mice.	HAND1 HAND2	4.28e-05	2	228	2	24857828
Pubmed	The PTB domain: a new protein module implicated in signal transduction.	APBA1 APBA2	4.28e-05	2	228	2	7545337
Interaction	TRIM28 interactions	NR2C2 KIFBP ZNF140 ZNF562 PBK NAP1L1 ZNF302 ADAR RUVBL2 GFPT1 STAT4 SPDL1 STXBP2 ZNF778 ZNF480 PUM3 DNAH5 ZFP82 WEE1 HAT1 PTPN23 VTA1 ZNF317 PRPF8 RUFY1 ZNF181 ZNF2 RAD50 SSU72 UTP4 PRKACB NUP133 ZNF84 ATM CTPS1 SNRNP200 ATP5F1A	2.02e-06	1474	222	37	int:TRIM28
Interaction	KCNA3 interactions	ABCA13 SPEF2 RUVBL2 GFPT1 ADCY9 DST CEP95 VPS13A DNAH5 IMMT GOLGA4 AFF2 NEDD4L TTC28 DOCK10 PTPN23 RAD50 MACF1 CARD11 OCLN CTPS1 SMCR8 SNRNP200 ATP5F1A DOP1A TDRD12	4.02e-06	871	222	26	int:KCNA3
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF140 ZNF562 ZNF302 ZNF461 ZNF608 ZNF778 ZNF480 ZNF426 ZFP82 ZNF560 ZNF510 ZNF317 ZNF850 ZNF181 ZNF546 ZNF2 ZNF605 ZNF667 ZNF84	1.06e-05	718	153	19	28
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	KIFBP GTF3C3 TTC19 TTC12 TTC28 TMTC1 TTC21B	5.53e-05	115	153	7	769
GeneFamily	Transmembrane and coiled-coil domain containing	TMCC2 TMCC1	2.12e-04	3	153	2	774
GeneFamily	Intraflagellar transport proteins\|Tetratricopeptide repeat domain containing	IFT43 WDR19 TTC21B	1.06e-03	24	153	3	615
GeneFamily	Cation channels sperm associated	CATSPER4 CATSPERG	1.45e-03	7	153	2	186
GeneFamily	EF-hand domain containing\|Plakins	DST MACF1	1.93e-03	8	153	2	939
GeneFamily	Transglutaminases	TGM1 TGM7	2.46e-03	9	153	2	773
Coexpression	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D	MYO1A MID1IP1 TMCC2 DIAPH2 ZNF778 ALDH1B1 ZNF850 CRMP1 ATP6AP2 CARD11 CTPS1 PRL	1.05e-05	293	227	12	MM895
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	PBK NAP1L1 ZNF302 JAKMIP2 DMXL1 SPDL1 SMPDL3A GOLIM4 PUM3 PPIP5K2 TASOR GOLGA4 USP47 DOCK10 RAD50 LACTB2 ATM SPESP1	1.84e-05	656	227	18	M18979
Coexpression	GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_UP	NR2C2 DMXL1 CEP95 PARP8 CBLB RGS10 MTIF2 AKAP10 CTPS1	2.22e-05	174	227	9	M6296
Coexpression	ZHENG_BOUND_BY_FOXP3	NT5C3A SPEF2 TLR8 STAT4 ZNF608 TRAT1 CC2D2A ABTB2 ZNF560 PARP8 DOCK10 CBLB RGS10 MACF1 RAPGEF2	3.24e-05	498	227	15	M1741
Coexpression	DESCARTES_ORGANOGENESIS_EPENDYMAL_CELL	ENKUR CDHR3 SPEF2 ENO4 EFHC1 TTC12 CFAP47 CFAP43 AK8 WDR19 EFHC2	3.83e-05	282	227	11	MM3642
Coexpression	ZHENG_BOUND_BY_FOXP3	NT5C3A SPEF2 TLR8 STAT4 ZNF608 TRAT1 CC2D2A ZNF778 ABTB2 PARP8 DOCK10 CBLB RGS10 MACF1 RAPGEF2	3.98e-05	507	227	15	MM1030
Coexpression	MEK_UP.V1_DN	ZNF140 DLC1 SMPDL3A IFI44L TAF2 GOLGA4 RASGRP1 MTIF2 ZNF84	5.20e-05	194	227	9	M2724
Coexpression	GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_UP	FBXO40 TTC19 TASOR RUFY1 PABPC3 PRKACB VPS28 DCLK1 DOP1A	6.09e-05	198	227	9	M5577
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	INHBB ADCY9 DLC1 DST PTX3 VPS13A PUM3 PPIP5K2 TASOR GOLGA4 TTC28 HAT1 CBLB MTIF2 PRKACB NUP133 MACF1 AKAP10 RAPGEF2 TMCC1	6.10e-05	856	227	20	M4500
Coexpression	GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_UP	MYO1A INPP5A PTDSS1 RUVBL2 ADCY9 ALDH1B1 MCF2L WEE1 DOCK10	6.33e-05	199	227	9	M5258
Coexpression	GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_UP	NT5C3A DIAPH2 KDR IFI44L CLEC10A ABTB2 HAT1 RGS18 SMCR8	6.58e-05	200	227	9	M6256
Coexpression	GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_DN	NEB ADAR ENO4 KDR IFI44L TTC28 MXRA8 CFAP43 DOP1A	6.58e-05	200	227	9	M6789
Coexpression	GSE40273_XBP1_KO_VS_WT_TREG_UP	ADCY9 STAT4 PCTP ZNF608 ALDH1B1 CIR1 HAT1 RGS18 FRMD6	6.58e-05	200	227	9	M9123
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	ADCY9 DST VPS13A IFI44L PPIP5K2 WEE1 CBLB MTIF2 RAPGEF2 TMCC1 DOP1A	6.68e-05	300	227	11	M8702
Coexpression	ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN	VWA8 TIGD1 NAP1L1 STAT4 TRAT1 CEP95 VPS13A VPS51 ZFP82 CAMK1D WEE1 APBA2 PRPF8 CBLB ZNF181 RASGRP1 PRKACB MACF1 CARD11 ZNF84 ATM SNRNP200	7.51e-05	1012	227	22	M40864
Coexpression	TRAVAGLINI_LUNG_CILIATED_CELL	ENKUR INHBB ABCA13 CDHR3 NT5C3A SPEF2 NAP1L1 RUVBL2 IFT43 ENO4 PROM1 EFHC1 TTC12 CC2D2A IFI44L DNAH5 CFAP47 CIR1 CFAP43 AK8 WDR19 EFHC2 TTC21B	8.36e-05	1093	227	23	M41649
Coexpression	DESCARTES_MAIN_FETAL_CILIATED_EPITHELIAL_CELLS	ENKUR ABCA13 CDHR3 SPEF2 RUVBL2 IFT43 ENO4 EFHC1 TTC12 CC2D2A SMIM34 DNAH5 CFAP47 CFAP43 AK8 WDR19 TTC21B	9.52e-05	678	227	17	M40124
Coexpression	DESCARTES_FETAL_STOMACH_CILIATED_EPITHELIAL_CELLS	ENKUR ABCA13 CDHR3 SPEF2 EFHC1 CC2D2A DNAH5 CFAP47 CFAP43 AK8 EFHC2	1.09e-04	317	227	11	M40298
Coexpression	ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP	ZNF608 CC2D2A SGIP1	1.33e-04	12	227	3	M1748
Coexpression	ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP	ZNF608 CC2D2A SGIP1	1.33e-04	12	227	3	MM732
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	RAPH1 JAKMIP2 TTC19 PROM1 SUPT6H TASOR GOLGA4 WEE1 CIR1 ZNF2 RAD50 KCNT2 CCZ1 MTIF2 SSX2IP MACF1 RAPGEF2 CLSPN POLG2 SNRNP200	4.50e-06	595	221	20	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
ToppCell	Control-T_cells-CD8+_T_cells\|Control / group, cell type (main and fine annotations)	JAKMIP2 STAT4 TRAT1 DOCK2 PARP8 APBA2 DOCK10 CBLB RASGRP1 CARD11 ATM	3.15e-09	185	227	11	02ab64c0166c0646d1d4c6ed110ef0b75a1096d0
ToppCell	COVID-19-Heart-T_cell\|Heart / Disease (COVID-19 only), tissue and cell type	ABCA13 JAKMIP2 STAT4 TRAT1 TMCC2 DOCK2 PARP8 APBA2 DOCK10 RASGRP1 CARD11	4.17e-09	190	227	11	e6c3a6e01fef6c5b49f72661d4fb0414ba9046bf
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ENKUR ABCA13 CDHR3 SPEF2 PROM1 EFHC1 CC2D2A DNAH5 CFAP47 CFAP43 EFHC2	6.08e-09	197	227	11	91637bdeab85024b5a02d1066f76cb803a2d6420
ToppCell	megakaryocytic-Platelet\|megakaryocytic / Lineage and Cell class	ENKUR VWA8 NT5C3A MAX NAP1L1 TMCC2 GNAZ RUFY1 RGS10 RGS18	4.10e-08	185	227	10	436f0ab9016c5b8b7315d5974de80af6b3a999d2
ToppCell	Control-T_cells\|Control / group, cell type (main and fine annotations)	STAT4 TRAT1 DOCK2 PARP8 APBA2 DOCK10 CBLB RASGRP1 CARD11 ATM	4.54e-08	187	227	10	f4e8e0eba58da89b56587667555a5d4754e108c7
ToppCell	COVID-19-lung-Ciliated\|lung / Disease (COVID-19 only), tissue and cell type	ENKUR ABCA13 CDHR3 SPEF2 PROM1 DNAH5 CFAP47 CFAP43 AK8 EFHC2	5.02e-08	189	227	10	27329c4661aebabd19fac7fe5dca263fe99d76f3
ToppCell	COVID-19-T_cells-CD8+_T_cells\|COVID-19 / group, cell type (main and fine annotations)	JAKMIP2 STAT4 TRAT1 PARP8 APBA2 DOCK10 CBLB RASGRP1 PRKACB CARD11	5.02e-08	189	227	10	2c018d6120f65f0b2704b483bc9da1c0984872e3
ToppCell	nucseq-Epithelial-Epithelial_Airway\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ENKUR ABCA13 CDHR3 SPEF2 PROM1 DNAH5 CFAP47 CFAP43 AK8 EFHC2	5.54e-08	191	227	10	1c528f72c9ef3ef3a850b05e4a9715190832270c
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ENKUR ABCA13 CDHR3 SPEF2 PROM1 DNAH5 CFAP47 CFAP43 AK8 EFHC2	5.54e-08	191	227	10	e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ENKUR ABCA13 CDHR3 SPEF2 PROM1 DNAH5 CFAP47 CFAP43 AK8 EFHC2	5.54e-08	191	227	10	9d31c8424d35bdc0c27188b68bfd0f731af3600b
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ENKUR ABCA13 CDHR3 SPEF2 PROM1 EFHC1 CC2D2A DNAH5 CFAP43 EFHC2	6.11e-08	193	227	10	e1b76102f812c433195d1e8811fdd3293a7bc22e
ToppCell	COVID-19-lung-CD8+_T_cells\|lung / Disease (COVID-19 only), tissue and cell type	STAT4 TRAT1 DOCK2 PARP8 APBA2 DOCK10 CBLB RASGRP1 PRKACB CARD11	6.11e-08	193	227	10	780e23e2705fc5c1b70e37568b79731ced5038bd
ToppCell	NS-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ENKUR ABCA13 CDHR3 SPEF2 PROM1 EFHC1 CC2D2A DNAH5 CFAP43 EFHC2	6.73e-08	195	227	10	34e37cff4849696ca4ba5dd8fd2cf98fed8bc912
ToppCell	NS-moderate-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ENKUR CDHR3 SPEF2 PROM1 EFHC1 DIAPH2 CC2D2A DNAH5 CFAP47 CFAP43	7.41e-08	197	227	10	71fea4aa6ce96c7693fa94792d08770622873850
ToppCell	NS-critical-d_07-13-Epithelial-Ciliated-diff\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ENKUR ABCA13 CDHR3 SPEF2 IFT43 PROM1 EFHC1 CC2D2A DNAH5 CFAP43	7.41e-08	197	227	10	32484fb5dde0a4525dd8028dde01ca5a4e51e4b6
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ENKUR ABCA13 CDHR3 SPEF2 PROM1 EFHC1 DNAH5 CFAP47 CFAP43 EFHC2	7.41e-08	197	227	10	22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ENKUR ABCA13 CDHR3 SPEF2 PROM1 EFHC1 DNAH5 CFAP47 CFAP43 EFHC2	7.41e-08	197	227	10	3bbf068d2ad8196fbc85d3f311a7c54c9aece856
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ENKUR ABCA13 CDHR3 SPEF2 PROM1 EFHC1 DNAH5 CFAP47 CFAP43 EFHC2	7.41e-08	197	227	10	87db09f341e2b20eb6e1c3e917cb5c960387b3e9
ToppCell	Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	DST ZNF778 ALDH1B1 APBA1 ARHGEF25 ZNF850 CRMP1 WDR19 UTP4 ZNF84	7.77e-08	198	227	10	cc2b5b632e73e44bb60050f0db10d8f0dbb859fa
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	JAKMIP2 STAT4 TRAT1 DOCK2 PARP8 APBA2 DOCK10 CBLB RASGRP1 CARD11	8.54e-08	200	227	10	02c4169a23e5aaa0d4bfc78b51ba19ce8157dc3e
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_GZMK+\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	JAKMIP2 STAT4 TRAT1 DOCK2 PARP8 APBA2 DOCK10 CBLB RASGRP1 CARD11	8.54e-08	200	227	10	510d84bf7a4621b079e5a7330d25e04508c84a49
ToppCell	COVID-19-Epithelial_cells-Airway_mucous\|COVID-19 / group, cell type (main and fine annotations)	ABCA13 CDHR3 SPEF2 NEFL DNAH5 CFAP47 NEDD4L CFAP43 AK8	8.57e-08	151	227	9	8216462e723fec2797387929dde095370947e10a
ToppCell	LPS-IL1RA-Lymphocytic_NKT-T_cells-T-cells\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NCLN STAT4 TRAT1 DOCK2 APBA2 DOCK10 RGS10 RASGRP1 CARD11	2.48e-07	171	227	9	539ea88acc6f948efdeae8b69e5c5ffaee29f1d9
ToppCell	LPS-IL1RA-Lymphocytic_NKT-T_cells\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NCLN STAT4 TRAT1 DOCK2 APBA2 DOCK10 RGS10 RASGRP1 CARD11	2.60e-07	172	227	9	0fc692be845d4225ff8b63bf9195724fc8510c2c
ToppCell	cellseq-Immune-Hematopoietic-Megakaryocyte/Platelet\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ENKUR NT5C3A MAX TMCC2 GNAZ RUFY1 RGS10 RGS18 SSX2IP	2.60e-07	172	227	9	eb2915165cab2660511e4b70c3a6d3ab2f770809
ToppCell	cellseq-Immune-Hematopoietic-Megakaryocyte/Platelet-Megakaryocyte/Platelet\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ENKUR NT5C3A MAX TMCC2 GNAZ RUFY1 RGS10 RGS18 SSX2IP	2.60e-07	172	227	9	d0c3fb48c61762dcefca858cf13c9da8eb6d0f5e
ToppCell	LPS-antiTNF-Lymphocytic_NKT-T_cells-T-cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NCLN STAT4 TRAT1 DOCK2 APBA2 DOCK10 RGS10 RASGRP1 CARD11	3.16e-07	176	227	9	bfbab3c5b738b3b0b1540f2059d0245fbd8c0031
ToppCell	LPS-antiTNF-Lymphocytic_NKT-T_cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NCLN STAT4 TRAT1 DOCK2 APBA2 DOCK10 RGS10 RASGRP1 CARD11	3.16e-07	176	227	9	ea27e18407b8a13e8212830da859efeb8f158690
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ENKUR MARK1 PBK TTC19 TTC12 DNAH5 CFAP43 GINS2 CLSPN	3.48e-07	178	227	9	6178706db4a855d72abc156537604d575624df56
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ENKUR MARK1 PBK TTC19 TTC12 DNAH5 CFAP43 GINS2 CLSPN	3.48e-07	178	227	9	f02076ece0fa899e620971c887ad4da7f48684ed
ToppCell	Control-Epithelial_cells-Airway_ciliated\|Control / group, cell type (main and fine annotations)	ABCA13 CDHR3 SPEF2 PROM1 DNAH5 CFAP47 CFAP43 AK8 EFHC2	4.19e-07	182	227	9	fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f
ToppCell	COVID-19-Epithelial_cells-Airway_ciliated\|COVID-19 / group, cell type (main and fine annotations)	ABCA13 CDHR3 SPEF2 PROM1 DNAH5 CFAP47 CFAP43 AK8 EFHC2	4.81e-07	185	227	9	18a40f0a338aa398d81384b5159fb80ce8a2020c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	STAT4 TRAT1 DOCK2 PARP8 APBA2 DOCK10 RASGRP1 CARD11 ATM	5.03e-07	186	227	9	9d576dce2c5deefef1adda16c6da7055c8d57f8f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	STAT4 TRAT1 DOCK2 PARP8 APBA2 DOCK10 RASGRP1 CARD11 ATM	5.03e-07	186	227	9	bd3bd022b575d9b0ef90d50a5cb874085a827b77
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	STAT4 TRAT1 DOCK2 PARP8 APBA2 DOCK10 RASGRP1 CARD11 ATM	5.03e-07	186	227	9	924cc357b4c4ce8e9b05773bdab544f0b65474cc
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	THSD4 MYH6 CLTCL1 NEB STAT4 GREB1L MYO18B CAMK1D NEDD4L	5.51e-07	188	227	9	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	Ciliated\|World / Class top	ENKUR CDHR3 SPEF2 IFT43 ENO4 EFHC1 DNAH5 CFAP43 AK8	5.51e-07	188	227	9	cc9178361360b5800f96516ed6a65089c144b1ce
ToppCell	COVID-19-lung-Ciliated\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ENKUR ABCA13 CDHR3 SPEF2 DNAH5 CFAP47 CFAP43 AK8 EFHC2	5.76e-07	189	227	9	a2da5debd10f27b1280b40141ef0bfef007cc72c
ToppCell	Healthy-Platelet\|World / disease group, cell group and cell class	ENKUR NT5C3A MAX TMCC2 GNAZ RUFY1 RGS10 RGS18 SSX2IP	5.76e-07	189	227	9	c3d8e3682cb489bca887039cbea6c4cfc264de2f
ToppCell	COPD-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	ABCA13 CDHR3 SPEF2 EFHC1 DNAH5 CFAP47 CFAP43 AK8 EFHC2	5.76e-07	189	227	9	3e77883db34722b9ce0a03ea74caefc92dc7feff
ToppCell	PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_1\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ENKUR NT5C3A MAX TMCC2 GNAZ RUFY1 RGS10 RGS18 SSX2IP	6.02e-07	190	227	9	427038bae9c7b3a9441c8d59ace69da74e9d37bf
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	JAKMIP2 STAT4 TRAT1 DOCK2 PARP8 APBA2 DOCK10 RASGRP1 CARD11	6.02e-07	190	227	9	5b4b3eed7aa798bb7e3c5e968c8dc4144e377a5f
ToppCell	COVID-19_Moderate-Platelet\|COVID-19_Moderate / disease group, cell group and cell class	ENKUR NT5C3A MAX TMCC2 GNAZ RUFY1 RGS10 RGS18 SSX2IP	6.02e-07	190	227	9	3bf4ab3fd3a391da98a83e2aac0881a0e5c8f8b0
ToppCell	PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_1\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ENKUR NT5C3A MAX TMCC2 GNAZ RUFY1 RGS10 RGS18 SSX2IP	6.02e-07	190	227	9	b719061be370ffc293854f1f6e526bf33cd2f442
ToppCell	COVID-19_Moderate-Platelet\|World / disease group, cell group and cell class	ENKUR NT5C3A MAX TMCC2 GNAZ RUFY1 RGS10 RGS18 SSX2IP	6.02e-07	190	227	9	6e4f4af5ba185bb022753881a26a269a544bb59b
ToppCell	Control-T_cells-CD4+_T_cells\|Control / group, cell type (main and fine annotations)	STAT4 TRAT1 DOCK2 PARP8 APBA2 DOCK10 CBLB RASGRP1 CARD11	6.02e-07	190	227	9	0733be5e54fe15d6d6ea51c154a95258e83f1b92
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	JAKMIP2 STAT4 TRAT1 DOCK2 PARP8 APBA2 DOCK10 RASGRP1 CARD11	6.02e-07	190	227	9	07ea0578ca0561077557203ae660530f53fc4067
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	STAT4 TRAT1 DOCK2 PARP8 APBA2 DOCK10 CBLB RASGRP1 CARD11	6.29e-07	191	227	9	d9506b88d806aadd4c2b9bf86fe994c47799e7f6
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	JAKMIP2 STAT4 TRAT1 DOCK2 PARP8 APBA2 DOCK10 RASGRP1 CARD11	6.29e-07	191	227	9	96a7179a845d3daa046ed71fa45c51255f130a7f
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	STAT4 TRAT1 DOCK2 PARP8 APBA2 DOCK10 CBLB RASGRP1 CARD11	6.29e-07	191	227	9	9aabbc65430e2233b8f2d3fff9face7807b88b48
ToppCell	COVID-19-T_cells\|COVID-19 / group, cell type (main and fine annotations)	STAT4 TRAT1 DOCK2 PARP8 APBA2 DOCK10 CBLB RASGRP1 CARD11	6.29e-07	191	227	9	7f64add931b64b8d35836fa6bee9ebab593844d3
ToppCell	PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ENKUR CDHR3 SPEF2 ENO4 TTC12 DNAH5 CFAP43 AK8 EFHC2	6.29e-07	191	227	9	96483adb97c81208aa513782550acd8a08b63866
ToppCell	PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_1\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ENKUR NT5C3A MAX TMCC2 GNAZ RUFY1 RGS10 RGS18 SSX2IP	6.29e-07	191	227	9	7da172553ed6df4a0c34ecd55665a9598b5071a5
ToppCell	PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_1\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ENKUR NT5C3A MAX TMCC2 GNAZ RUFY1 RGS10 RGS18 SSX2IP	6.29e-07	191	227	9	1a1bf85bc77bf093a0ac2cb9eabaeac820a7b93e
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	STAT4 TRAT1 DOCK2 PARP8 APBA2 DOCK10 CBLB RASGRP1 CARD11	6.29e-07	191	227	9	b42c54308abe1241cc38ddce96b9d38d07983891
ToppCell	COVID-19-lung-CD8+_T_cells\|COVID-19 / Disease (COVID-19 only), tissue and cell type	STAT4 TRAT1 DOCK2 PARP8 APBA2 DOCK10 CBLB RASGRP1 CARD11	6.29e-07	191	227	9	543f8ae07cc2e6950c888115a5ca9445e3c0f618
ToppCell	Control-PLT_1\|World / Disease Group and Platelet Clusters	ENKUR VWA8 NT5C3A MAX TMCC2 GNAZ RUFY1 RGS18 SSX2IP	6.57e-07	192	227	9	f595eba81911eb860dce964f1d8269287f50d3ea
ToppCell	COPD-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	ABCA13 CDHR3 SPEF2 PROM1 DNAH5 CFAP47 CFAP43 AK8 EFHC2	6.57e-07	192	227	9	eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CLEC10A MNDA DOCK2 MRC1 CAMK1D DOCK10 RGS10 RGS18 CARD11	6.86e-07	193	227	9	3e3d7cb3e7242ec9c9677e07e303835649852b52
ToppCell	Control-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	ABCA13 CDHR3 SPEF2 EFHC1 DNAH5 CFAP47 CFAP43 AK8 EFHC2	6.86e-07	193	227	9	0e37d454f3735edd936ee9a5f5f516ac3aad400e
ToppCell	Children_(3_yrs)-Immune-T_lymphocyte\|Children_(3_yrs) / Lineage, Cell type, age group and donor	STAT4 TRAT1 DOCK2 PARP8 APBA2 DOCK10 CBLB RASGRP1 CARD11	6.86e-07	193	227	9	b9769b45125d2244afe53f9f71c92c04ddccf980
ToppCell	COVID-19-kidney-T-cells-1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	STAT4 TRAT1 DOCK2 PARP8 APBA2 DOCK10 RASGRP1 CARD11 ATM	6.86e-07	193	227	9	5b84fa640cf30dea55fde53b810f850ff946d253
ToppCell	COVID-19-lung-NK/NKT\|COVID-19 / Disease (COVID-19 only), tissue and cell type	JAKMIP2 STAT4 DOCK2 PARP8 APBA2 DOCK10 RASGRP1 CARD11 ATM	6.86e-07	193	227	9	c24b44fcc92fff42ebba6f1aff91c7aaea179e56
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	JAKMIP2 STAT4 DOCK2 MRC1 PARP8 DOCK10 CARD11 ATM IGSF21	7.16e-07	194	227	9	4dfc890bacf133cfb6ec7c8b73f084f2491cf78e
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	THSD4 FBXO40 MYH6 STAT4 GREB1L CKMT2 ZNF608 MYO18B NEDD4L	7.16e-07	194	227	9	c3535f7cc0076653c72db582047cff053c322397
ToppCell	Immune-T_lymphocyte\|World / Lineage, Cell type, age group and donor	STAT4 TRAT1 DOCK2 PARP8 APBA2 DOCK10 RASGRP1 CARD11 ATM	7.16e-07	194	227	9	f47fa18c87b35a3960557f8169ff7830dd6ecb80
ToppCell	Children_(3_yrs)-Immune-T_lymphocyte-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	STAT4 TRAT1 PARP8 APBA2 DOCK10 CBLB RASGRP1 PRKACB CARD11	7.16e-07	194	227	9	3d6f2d190dd50804afea299957cc44c2bb756134
ToppCell	COVID-19-lung-NK_cells\|COVID-19 / Disease (COVID-19 only), tissue and cell type	JAKMIP2 STAT4 DOCK2 PARP8 APBA2 DOCK10 RASGRP1 CARD11 ATM	7.16e-07	194	227	9	4c92f18e0a34fb50630d4b260eaf179202508b6d
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SPEF2 DLC1 DST ZNF608 KDR MCF2L PLSCR4 FAT4 MACF1	7.16e-07	194	227	9	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	COVID-19-Epithelial-Ciliated_cells\|COVID-19 / Condition, Lineage and Cell class	ENKUR ABCA13 CDHR3 SPEF2 PROM1 EFHC1 DNAH5 CFAP47 CFAP43	7.16e-07	194	227	9	43be5fbd51dd58839cb03ca3ddd05a458e1ddb74
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	THSD4 FBXO40 MYH6 MYH7 GREB1L CKMT2 DST ALPK3 MYO18B	7.48e-07	195	227	9	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	moderate-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ENKUR CDHR3 SPEF2 EFHC1 DIAPH2 CC2D2A DNAH5 CFAP43 EFHC2	7.48e-07	195	227	9	3486eae5fdb062a75a907b896c9d7b396d2aa195
ToppCell	BL-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ENKUR CDHR3 SPEF2 PROM1 EFHC1 CC2D2A DNAH5 CFAP43 EFHC2	7.48e-07	195	227	9	07a6bcef6af93ed87df455dee624037cb75e011a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	STAT4 DOCK2 MRC1 CAMK1D PARP8 APBA2 DOCK10 CARD11 IGSF21	7.48e-07	195	227	9	7b6c69df943842b566a596e30bb50dbe80dccc83
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZNF302 STAT4 TRAT1 PARP8 APBA2 CBLB RASGRP1 PRKACB ATM	7.80e-07	196	227	9	c4e7133c609bcbc48c4947ea0aa1a7d9d7251b04
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CLEC10A MNDA DOCK2 MRC1 CAMK1D DOCK10 RGS10 RGS18 IGSF21	7.80e-07	196	227	9	4370473693d2dd4a8c451a4c477eb79baa33ae12
ToppCell	(05)_Ciliated\|World / shred by cell type and Timepoint	ENKUR CDHR3 SPEF2 ENO4 EFHC1 DNAH5 CFAP43 AK8 WDR19	8.14e-07	197	227	9	fee3cd16af8eea697cd64e8f64af505aaa2ac4b0
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	STAT4 MNDA DOCK2 MRC1 CAMK1D PARP8 DOCK10 CARD11 IGSF21	8.14e-07	197	227	9	0523aec9713ae21e6b879aa98e07fa2576610d5f
ToppCell	control-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ENKUR CDHR3 SPEF2 PROM1 EFHC1 DIAPH2 CC2D2A DNAH5 CFAP43	8.14e-07	197	227	9	e453d085182364ca347cbcc9dc995c62c3353016
ToppCell	COVID-19-kidney-T-cells-1\|kidney / Disease (COVID-19 only), tissue and cell type	STAT4 TRAT1 DOCK2 PARP8 APBA2 DOCK10 CBLB RASGRP1 CARD11	8.14e-07	197	227	9	9bb7faf4ef63cca4d06c60e6c05a9616fdb6b98e
ToppCell	control-Epithelial-Ciliated\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ENKUR CDHR3 SPEF2 PROM1 EFHC1 DIAPH2 CC2D2A DNAH5 CFAP43	8.14e-07	197	227	9	d4e963c1f82996371bf3d63578ee9fce8e00c5a8
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 NAP1L1 DLC1 PTX3 FAT4 SGIP1 CBLB FRMD6 DCLK1	8.49e-07	198	227	9	a860246bcea847249a78fd2e86ed8e04371060db
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CLEC10A MNDA DOCK2 MRC1 CAMK1D DOCK10 RGS10 RGS18 IGSF21	8.49e-07	198	227	9	96883ad8e189a46ed5b7eaafc0543e53682d26ed
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytokine_secreting_effector_T_cell\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	JAKMIP2 STAT4 GOLGA4 PARP8 APBA2 CBLB PRKACB MACF1 ATM	8.49e-07	198	227	9	34c564ece9a2b94dcf646e3c95b5be9c5ecfaafe
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CLEC10A MNDA DOCK2 MRC1 CAMK1D DOCK10 RGS10 RGS18 IGSF21	8.85e-07	199	227	9	04adf46975aa4194ea40c7480f8a517def5d929c
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ALPK3 MNDA PGBD5 DOCK2 DOCK10 RGS10 RGS18 CARD11 IGSF21	8.85e-07	199	227	9	744b63fba33b176ab7dde11646ccb313665505f7
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_CTL\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	JAKMIP2 STAT4 TRAT1 DOCK2 PARP8 DOCK10 RASGRP1 CARD11 ATM	8.85e-07	199	227	9	eb188b0b457136b6ee485d3b3052baa30d9c0002
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	STAT4 VPS13A IFI44L GOLGA4 PARP8 CBLB MACF1 ATM SNRNP200	8.85e-07	199	227	9	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	droplet-Pancreas-Exocrine-18m-Hematologic\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDHR3 SKA2 TLR8 MNDA MRC1 RGS10 TGM1 RGS18	9.06e-07	147	227	8	684e2d8d2f0516cf8b0dc53efa7efc3050bbf0d1
ToppCell	droplet-Pancreas-Exocrine-18m-Hematologic-leukocyte\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDHR3 SKA2 TLR8 MNDA MRC1 RGS10 TGM1 RGS18	9.06e-07	147	227	8	c031fad0a4e192019775809968e46da54a111d27
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_GZMK+\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	STAT4 TRAT1 DOCK2 PARP8 APBA2 DOCK10 CBLB RASGRP1 CARD11	9.23e-07	200	227	9	7a9c3f51d4a8fda5f1b7e0be6fcf9c1c92fffe99
ToppCell	COVID-19-COVID-19_Severe-Others-Platelet\|COVID-19_Severe / Disease, condition lineage and cell class	ENKUR NT5C3A MAX NAP1L1 GNAZ RUFY1 RGS10 RGS18 SSX2IP	9.23e-07	200	227	9	af373636f540544addd94f51ce94ea2cb1f3ecc9
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_TRM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	JAKMIP2 STAT4 DOCK2 PARP8 APBA2 DOCK10 CBLB RASGRP1 CARD11	9.23e-07	200	227	9	be9a43acc2f926b9433ab3f018b911b03896a924
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	SPEF2 DLC1 DST ZNF608 DIAPH2 KDR MCF2L FAT4 MACF1	9.23e-07	200	227	9	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ENKUR ABCA13 CDHR3 SPEF2 PROM1 EFHC1 DNAH5 CFAP47 CFAP43	9.23e-07	200	227	9	f1a49bc818054fb0734d3b84725ee6487b034567
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-gdT\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	STAT4 TRAT1 ZFP82 DOCK2 PARP8 DOCK10 RASGRP1 ZNF605 CARD11	9.23e-07	200	227	9	9996803c35444d32b76ab78b716674c3743f155a
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	JAKMIP2 STAT4 NEFL DOCK2 APBA2 DOCK10 GINS2 CARD11 ATM	9.23e-07	200	227	9	bfbd2ccf4b28901aad63d70a382a8247e4458ba6
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SPEF2 DLC1 DST ZNF608 DIAPH2 KDR MCF2L FAT4 MACF1	9.23e-07	200	227	9	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	COVID-19-COVID-19_Mild-Others\|COVID-19_Mild / Disease, condition lineage and cell class	ENKUR NT5C3A MAX TMCC2 GNAZ RUFY1 RGS10 RGS18 SSX2IP	9.23e-07	200	227	9	ecf94be4bb961ec343471547f2ea327bc6f709f4
ToppCell	mild-gd_T\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	STAT4 IFI44L GOLGA4 PARP8 CBLB RASGRP1 PRKACB MACF1 ATM	9.23e-07	200	227	9	109f673a4967ffa52270a0b4f818b3461288db44
Disease	Colorectal Carcinoma	ABCA13 JAKMIP2 PROM1 CABYR DLC1 VPS13A ZNF480 KDR ZNF560 PARP8 HAT1 LONRF2 IGSF21 SNRNP200 DCLK1	2.15e-04	702	215	15	C0009402
Disease	retinitis pigmentosa (is_implicated_in)	CC2D2A PRPF8 WDR19 SNRNP200	2.25e-04	41	215	4	DOID:10584 (is_implicated_in)
Disease	prolactinoma (biomarker_via_orthology)	NPY5R PRL	3.14e-04	4	215	2	DOID:5394 (biomarker_via_orthology)
Disease	Cardiomyopathy, Familial Hypertrophic, 1 (disorder)	MYH6 MYH7	3.14e-04	4	215	2	C3495498
Disease	Hypertrophic cardiomyopathy 1	MYH6 MYH7	3.14e-04	4	215	2	cv:C3495498
Disease	Cranioectodermal dysplasia	IFT43 WDR19	3.14e-04	4	215	2	cv:C4551571
Disease	Jeune thoracic dystrophy	WDR19 TTC21B	3.14e-04	4	215	2	cv:C0265275
Disease	Caveolinopathy	MYH6 MYH7	3.14e-04	4	215	2	cv:C5679790
Disease	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH6 MYH7	3.14e-04	4	215	2	192600
Disease	brain age measurement	INPP5A EEF1AKMT4-ECE2 ECE2	3.97e-04	20	215	3	EFO_0010602
Disease	age at menopause	INHBB CHUK CCZ1B SGIP1 TTC28 DOCK10 AK8 CCZ1 POLG2	3.98e-04	302	215	9	EFO_0004704
Disease	prenatal alcohol exposure	HAND1 HAND2	5.21e-04	5	215	2	C0678807
Disease	CRANIOECTODERMAL DYSPLASIA 1	IFT43 WDR19	5.21e-04	5	215	2	C0432235
Disease	sex interaction measurement, bilirubin measurement	FRMD6 SORCS3 IGSF21	5.30e-04	22	215	3	EFO_0004570, EFO_0008343
Disease	Psychosexual Disorders	GRIA1 PRL	7.78e-04	6	215	2	C0033953
Disease	Hypoactive Sexual Desire Disorder	GRIA1 PRL	7.78e-04	6	215	2	C0020594
Disease	Sexual Arousal Disorder	GRIA1 PRL	7.78e-04	6	215	2	C0036902
Disease	Frigidity	GRIA1 PRL	7.78e-04	6	215	2	C0016722
Disease	Orgasmic Disorder	GRIA1 PRL	7.78e-04	6	215	2	C0029261
Disease	lysophosphatidylethanolamine 16:0 measurement	ADCY9 GRIA1 SORCS3	8.76e-04	26	215	3	EFO_0010366
Disease	Retinitis Pigmentosa	PROM1 IMPG2 CCZ1B PRPF8 SNRNP200	1.00e-03	104	215	5	C0035334
Disease	Pseudo-TORCH syndrome	ADAR OCLN	1.08e-03	7	215	2	C3489725
Disease	Idiopathic hypertrophic subaortic stenosis	MYH6 MYH7	1.08e-03	7	215	2	C0700053
Disease	Obstructive asymmetric septal hypertrophy	MYH6 MYH7	1.08e-03	7	215	2	C0597124
Disease	Ciliopathies	IFT43 CC2D2A DNAH5 WDR19 TTC21B	1.29e-03	110	215	5	C4277690
Disease	interleukin-6 measurement	EFCAB13 ADAR NEFL MYO3A AK8	1.40e-03	112	215	5	EFO_0004810
Disease	alcohol-related neurodevelopmental disorder (implicated_via_orthology)	TMCC2 TMCC1	1.44e-03	8	215	2	DOID:0050667 (implicated_via_orthology)
Disease	Myopathies, Nemaline	NEB NEFL	1.44e-03	8	215	2	C0206157
Disease	P wave terminal force measurement	MYH6 ALPK3	1.44e-03	8	215	2	EFO_0008379
Disease	Cardiomyopathy, Hypertrophic, Familial	MYH6 MYH7	1.84e-03	9	215	2	C0949658
Disease	Retinitis pigmentosa	PROM1 IMPG2 PRPF8 SNRNP200	2.12e-03	74	215	4	cv:C0035334
Disease	Dermatologic disorders	INPP5A PTX3 GOLGA4 APBA2	2.22e-03	75	215	4	C0037274
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH6 MYH7	2.29e-03	10	215	2	DOID:0111269 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH6 MYH7	2.29e-03	10	215	2	DOID:0111602 (implicated_via_orthology)
Disease	primary biliary cholangitis (is_implicated_in)	STAT4 UTP4	2.29e-03	10	215	2	DOID:12236 (is_implicated_in)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH6 MYH7	2.29e-03	10	215	2	DOID:0111596 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH6 MYH7	2.29e-03	10	215	2	DOID:0110454 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH6 MYH7	2.29e-03	10	215	2	DOID:0080719 (implicated_via_orthology)
Disease	Muscular dystrophy, limb-girdle, autosomal dominant	MYH6 MYH7	2.29e-03	10	215	2	cv:C5675009
Disease	inclusion body myositis (implicated_via_orthology)	MYH6 MYH7	2.29e-03	10	215	2	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH6 MYH7	2.29e-03	10	215	2	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH6 MYH7	2.29e-03	10	215	2	DOID:0080326 (implicated_via_orthology)
Disease	autoimmune thyroid disease	SPEF2 STAT4 TRAT1 CBLB RASGRP1	2.35e-03	126	215	5	EFO_0006812
Disease	Jeune thoracic dystrophy	WDR19 TTC21B	2.78e-03	11	215	2	C0265275
Disease	vascular dementia (is_marker_for)	NEFL ATP5F1A	2.78e-03	11	215	2	DOID:8725 (is_marker_for)
Disease	left ventricular ejection fraction measurement	PROM1 ALPK3 NEDD4L	3.09e-03	40	215	3	EFO_0008373
Disease	triacylglycerol 54:9 measurement	IFT43 TMTC1	3.32e-03	12	215	2	EFO_0010427
Disease	distal myopathy (implicated_via_orthology)	MYH6 MYH7	3.32e-03	12	215	2	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH6 MYH7	3.32e-03	12	215	2	DOID:2106 (implicated_via_orthology)
Disease	liver cirrhosis (implicated_via_orthology)	RAD50 UTP4	3.91e-03	13	215	2	DOID:5082 (implicated_via_orthology)
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH6 MYH7	3.91e-03	13	215	2	DOID:397 (implicated_via_orthology)
Disease	male infertility (implicated_via_orthology)	CABYR CFAP47	3.91e-03	13	215	2	DOID:12336 (implicated_via_orthology)
Disease	Nephronophthisis	WDR19 TTC21B	3.91e-03	13	215	2	C0687120
Disease	left ventricular structural measurement	EFCAB13 ALPK3 HAND1 MYO18B	3.97e-03	88	215	4	EFO_0008205
Disease	Familial dilated cardiomyopathy	MYH6 MYH7 TAF1A	4.05e-03	44	215	3	C0340427
Disease	childhood aggressive behaviour measurement	INHBB DLC1 GRIA1 TTC21B	4.13e-03	89	215	4	EFO_0007663
Disease	Gastric Adenocarcinoma	MARK1 ATM DCLK1	4.32e-03	45	215	3	C0278701
Disease	emphysema imaging measurement	DLC1 ALDH1B1 DNAH5 WEE1 CATSPER4	4.41e-03	146	215	5	EFO_0007626
Disease	orotic acid measurement	NT5C3A ABTB2	4.54e-03	14	215	2	EFO_0010516
Disease	colonic neoplasm, overall survival	AFF2 RGS18	4.54e-03	14	215	2	EFO_0000638, EFO_0004288
Disease	age at last pregnancy measurement	SORCS3 LONRF2	4.54e-03	14	215	2	EFO_0009440
Disease	Hermansky-Pudlak syndrome (implicated_via_orthology)	CCZ1B CCZ1	4.54e-03	14	215	2	DOID:3753 (implicated_via_orthology)
Disease	Disorder of eye	PROM1 CC2D2A IMPG2 PRPF8 TTC21B SNRNP200	4.74e-03	212	215	6	C0015397
Disease	Cardiomyopathy, Dilated	MYH6 MYH7 ATM	5.18e-03	48	215	3	C0007193
Disease	S-warfarin to R-warfarin ratio measurement	MAX DLC1 GOLIM4 GRIA1	5.20e-03	95	215	4	EFO_0803331
Disease	glycerol-3-phosphate measurement	NEDD4L CFAP43	5.21e-03	15	215	2	EFO_0010488
Disease	distal arthrogryposis (implicated_via_orthology)	MYH6 MYH7	5.21e-03	15	215	2	DOID:0050646 (implicated_via_orthology)
Disease	Malignant neoplasm of breast	RAPH1 EFCAB13 COG3 ADAR STAT4 GOLIM4 KDR RUFY1 ZNF546 KCNT2 NUP133 MACF1 ATM OCLN CLSPN DOP1A	5.62e-03	1074	215	16	C0006142
Disease	Cardiomyopathy, Familial Idiopathic	MYH6 MYH7 ATM	5.81e-03	50	215	3	C1449563
Disease	Myasthenic Syndromes, Congenital, Slow Channel	GFPT1 ALG14	5.93e-03	16	215	2	C0751885
Disease	Endometrioma	NR2C2 SMPDL3A NEDD4L RASGRP1 PRL	6.63e-03	161	215	5	C0269102
Disease	Endometriosis	NR2C2 SMPDL3A NEDD4L RASGRP1 PRL	6.63e-03	161	215	5	C0014175
Disease	Congenital Myasthenic Syndromes, Postsynaptic	GFPT1 ALG14	6.69e-03	17	215	2	C0751883

Protein segments in the cluster

Peptide	Gene	Start	Entry
YMNQLSASLKETYAN	TDRD1	291	Q9BXT4
KLLDRMENYNIFNEY	TRHDE	766	Q9UKU6
IYIQSAKYDMAEDLL	TTC21B	1206	Q7Z4L5
NDRVDELLEKYMDSY	NT5C3A	301	Q9H0P0
SIEMDSYEKIYNLES	CATSPERG	736	Q6ZRH7
KYSYTSNSDDNMLKN	KCTD10	171	Q9H3F6
DYYQKLLISLSSAMD	CFAP43	726	Q8NDM7
LKYYNRAGMDTADLE	ARHGEF25	306	Q86VW2
IYSDFQTEKREYAME	CATSPER4	266	Q7RTX7
AQNDAMILYDKYFSL	AKAP10	431	O43572
ATQYNHDMKRKEREY	SSX2IP	191	Q9Y2D8
NDYEYRQKQILMENA	SSX2IP	261	Q9Y2D8
RDLDKAMYFTQALQA	ALDH1B1	451	P30837
YSRSLMEYFKQNASK	AFF2	1181	P51816
EMTELLSSSRNYDNY	RASGRP1	326	O95267
DYHMSQNEKREYLLR	FAT4	4216	Q6V0I7
QEVYFSLKDMYLENT	ALPK3	611	Q96L96
SMDTSLYYLRQEEDR	C13orf42	61	A0A1B0GVH6
QEYANEDYSRMIETL	ABCA13	2131	Q86UQ4
YYERTNMLLEKVAAA	DOP1A	161	Q5JWR5
AQLEENAKYSSVYME	CABYR	366	O75952
KEYSDIINTQEMYND	APBA2	541	Q99767
LDRADRDPSNMYTKY	ALG14	86	Q96F25
LLYNMLKDTAAENYF	DIAPH2	411	O60879
SVDSNLVAYNKQDMY	DMXL1	1111	Q9Y485
YDDLSKQAVAYRQMS	ATP5F1A	311	P25705
LNDMENYRLESAYEK	ANO8	421	Q9HCE9
SSLDNIEMAYARQIY	NUP93	176	Q8N1F7
MNYQEALKRTESAYD	RAPH1	511	Q70E73
AQMELQDYVQKTYSE	NR2C2	521	P49116
MSEKRNSQEDYLSYH	RASSF6	151	Q6ZTQ3
MRTTELVNKDLDIYY	RAD50	1111	Q92878
QDQIFNLMKYDSYSR	RGS10	131	O43665
NEYFTNEVLTKTYRM	NAP1L1	221	P55209
SEEYMAAADEYNRLK	OCLN	471	Q16625
QTLVASYEAYEDLMK	PTPN23	656	Q9H3S7
EYAYNDKAILEQRNM	PUM3	256	Q15397
SISDNAYQYMLTDRE	MYH7	156	P12883
LMRLLDFSYEQYQKA	NCLN	86	Q969V3
RSYRYALQDMDKFSL	PCDH18	856	Q9HCL0
SYDNATKQLDMVYDI	OTOA	286	Q7RTW8
SSNRERYDNLEMEYL	NUP133	826	Q8WUM0
RYDNLEMEYLQKRSD	NUP133	831	Q8WUM0
YSSNLRMEELYGLKN	PARP8	411	Q8N3A8
YLQMNSLKTEDTAVY	IGHV3-72	101	A0A0B4J1Y9
ELQYESLSEEMTYLK	KRT28	211	Q7Z3Y7
ELDYRKQALDQAYMR	JAKMIP2	701	Q96AA8
DMYSHYVLLKSIRND	MID1IP1	86	Q9NPA3
AQILDKATEYIQYMR	MAX	61	P61244
ELARAMEKNTDYVYE	MTIF2	101	P46199
MEKNTDYVYEALLNT	MTIF2	106	P46199
YLQMNSLKTEDTAVY	IGHV3-15	101	A0A0B4J1V0
MQAQYARDALAKNIY	MYO1A	336	Q9UBC5
KYSELVTAYQMLQRE	GOLGA4	156	Q13439
EQYSATVKDYELQTM	DST	1356	Q03001
SIQLDLERYSEQMTY	CHUK	486	O15111
SQNITAMREYYNEKL	SMPDL3A	261	Q92484
YVLDINSIDNLYSKM	IFI44L	321	Q53G44
SMLYFDDEYNIVKRD	INHBB	381	P09529
NKYTERDASGMLYNL	DCLK1	481	O15075
LSENEYFKIYIDSLM	CBLB	101	Q13191
NEKVLTAYLDYMEEL	ECE2	316	P0DPD6
FRLLNADEYTLNYME	EFHC2	521	Q5JST6
ADEYTLNYMEQNTDK	EFHC2	526	Q5JST6
LKMDLFYRNSADLEQ	AK8	431	Q96MA6
NRYDIKNNSDQMVYI	PLSCR4	141	Q9NRQ2
YYRDIAKMASISDQD	PLXNA3	1791	P51805
LSSDAMKEYNRARVY	INPP5A	76	Q14642
TTVFEDLYDYMNSLK	LACTB2	171	Q53H82
VYQLESTFDMKRYLS	HMX2	161	A2RU54
AMIDETRNSLYQYFL	IMMT	646	Q16891
EQLYSKYDEMSILFT	POLG2	426	Q9UHN1
SYIAYLMDVLAKDAQ	HAND1	141	O96004
LRAELYLTMKNYEQA	LONRF2	236	Q1L5Z9
YLTMKNYEQALQDAS	LONRF2	241	Q1L5Z9
SMLDTLLYQSFVKDY	KCNT2	891	Q6UVM3
DYNSYEINIDAMDKS	PCDHA5	311	Q9Y5H7
YLQMNSLKTEDTAVY	IGHV3-49	101	A0A0A0MS15
LLNKDMSSEEQSLYY	GREB1L	1271	Q9C091
NDLDMQLYDYAKDLF	HS6ST1	341	O60243
QYASTDMDRVLLKYT	MEF2B	56	Q02080
MELYSQLKAKEETYN	MACF1	6376	Q9UPN3
KEERQAYLTNEYMQR	PABPC3	371	Q9H361
MLYYELQTQLRKAEA	GOLIM4	31	O00461
SYIAYLMDLLAKDDQ	HAND2	146	P61296
YYIQMEKSARQAISD	PROX2	491	Q3B8N5
TLLADIYMDSDYRKQ	PCTP	66	Q9UKL6
IAINNAYILYKMSDA	PGBD5	481	Q8N414
VDALQKFADDMYSLY	ATP6AP2	241	O75787
YRESYISDNLDLDMD	FRMD6	346	Q96NE9
TANEKVLTAYLDYME	EEF1AKMT4-ECE2	386	P0DPD8
LYAEIYADKKSMDDQ	ATM	1956	Q13315
TQYQRIENYMKSSEF	ATM	2396	Q13315
TYRDLDNDLMKYSAI	IFT43	131	Q96FT9
TNYSHMENYRKREDL	IGSF21	81	Q96ID5
MENYRKREDLVYQST	IGSF21	86	Q96ID5
IYEKQALDNMFSSKY	GKN2	101	Q86XP6
YDLKLYEDNQTSRMA	GNAZ	231	P19086
DMSDAEQYRSYRLDI	HAT1	341	O14929
RLEYAFKDNSNLYMV	PRKACB	106	P22694
EYAQKMEEYRTSLQQ	CC2D2A	566	Q9P2K1
YQEELRSHYKDMLSE	DOCK10	2126	Q96BY6
NLLNFYKDNNREEMY	DOCK2	1206	Q92608
RFLYSELMKYNSQTA	ADAR	921	P55265
YKLLVYVTDDNLMSD	CDHR3	646	Q6ZTQ4
QDEGTKYRQMRDYLS	COG3	121	Q96JB2
MAQFDTEYQRLEASY	ATG9A	1	Q7Z3C6
DLEEDYNVMTSFKYQ	C3orf62	251	Q6ZUJ4
LEQDDMRILYKYLTT	CCZ1	236	P86791
LEQDDMRILYKYLTT	CCZ1B	236	P86790
ISEATAKYLDDRYEM	ADCY9	531	O60503
YSDLLNTQDMYNDDL	APBA1	631	Q02410
SMENYYKDQFSLLAE	CEP95	731	Q96GE4
DYDRYIQENLKKAAM	ENKUR	171	Q8TC29
KSNQYYSKIMENDDL	EFCAB13	341	Q8IY85
ERLKTAVDAKDYNMY	FBXO40	296	Q9UH90
DALINQKYDEVMATY	MARK1	351	Q9P0L2
AIYKEYESILNQDLM	MCF2L	516	O15068
TYKNAAEMVDLYVDL	ENO4	416	A6NNW6
LDTDEYVLKYMESNA	EFHC1	506	Q5JVL4
YLLESTMNEYIEQRK	GRIA1	716	P42261
QKKQAERERMYSYDD	CFAP47	651	Q6ZTR5
NYNLAMRYAQLSEEK	CARD11	201	Q9BXL7
KDVYQMSDSQLYEAF	CRMP1	171	Q14194
YLESSEALYNQYMKE	KIFBP	161	Q96EK5
YNTSNLMEDLKVLYR	DNAH5	2986	Q8TE73
LMKNADYFSNYVTED	OTUD5	251	Q96G74
LAENSDDYDLMYVNL	PTX3	16	P26022
YLQMNSLKTEDTAVY	IGHV3-73	101	A0A0B4J1V6
RYYKLSEMTEQDQQR	CKMT2	206	P17540
YTLSNMTYKEEDFER	PLA2G4D	766	Q86XP0
YDLGLTTKMQEEYNR	MNDA	31	P41218
QYYFSKEKETMDNAR	MRC1	811	P22897
SYRDIQDYDAMVKLV	MAP3K15	291	Q6ZN16
MADEESRLSAYYNLL	PRL	186	P01236
ESRSTQYMKEYQDAF	RUVBL2	436	Q9Y230
YSDESVSAMEKQYLR	MEIOC	196	A2RUB1
YDLQALNIKYAMDAF	UTP4	86	Q969X6
RDLLDTNDYEEYKNM	SPEF2	496	Q9C093
EDVYYSNLTSELKMT	SMIM34	81	A8MWV9
MFQKAESDLDYIQYR	SKA2	11	Q8WVK7
EENMDLLTTYKKDYN	SAXO1	96	Q8IYX7
SMEDLKTQLQRDYTY	TMCC2	536	O75069
VKYMYDNRESQDTSF	GFPT1	156	Q06210
LAYSLDQKLYSSMDF	SORCS3	311	Q9UPU3
MELSKLDKDDYAYNA	TAF1A	196	Q15573
KNKFSDNYYRAEMID	TAF2	786	Q6P1X5
DNYYRAEMIDALANS	TAF2	791	Q6P1X5
DLYATLNAEMNEYFK	TDRD12	906	Q587J7
MDLELDEYYNKTLAT	NPY5R	1	Q15761
LETYKQTRQGLDEMY	RUFY1	386	Q96T51
YYMELTKLLLNHASD	GINS2	91	Q9Y248
IDRMNYDSYLAQTGK	PROM1	626	O43490
MTESYEQEKYTLQRE	SPDL1	51	Q96EA4
NSVMRKLYGDADYLE	CTPS1	461	P17812
NMLCNSRSKLYEYLD	SPESP1	301	Q6UW49
YMALKQYREAAQTAI	WDR19	1096	Q8NEZ3
YNTMNLAIDKYSLDV	IMPG2	991	Q9BZV3
SISDNAYQYMLTDRE	MYH6	156	P13533
QKYMENLSKEYQTLE	MTRF1	76	O75570
QSAYDVADMLKQYFR	DLC1	1141	Q96QB1
LYYSQDEESKIMISD	CAMK1D	151	Q8IU85
MIYLARNAKDVSVSY	SULT1B1	126	O43704
DLNYFSLRIMSVDYQ	SMCR8	86	Q8TEV9
ELSESYAFLMVDRYQ	TASOR	176	Q9UK61
QLARDMAKSYYEAND	GTF3C3	291	Q9Y5Q9
RTRTKALQEAMYYSA	ABTB2	711	Q8N961
MEYISRLDNYDALDI	CLTCL1	1041	P53675
YLKEQESYDNRLLMG	CIR1	46	Q86X95
MTRTYENFQYLENKV	CLEC10A	1	Q8IUN9
DESYMEKSLYQENLE	CLSPN	111	Q9HAW4
KLNSEEMKEAYYQTL	RIOK3	376	O14730
RAKFLDYTTDNMSIY	PRPF8	1681	Q6P2Q9
ENLTRLFEKMQAYQY	SUPT6H	411	Q7KZ85
SMDELKDVYNHFLLY	SUPT6H	456	Q7KZ85
KDLYEDVMLENYRNL	ZNF667	36	Q5HYK9
LSGRYYLKNNMETET	RAPGEF2	681	Q9Y4G8
DSDMQTLVYENYNKF	VPS51	101	Q9UID3
DEAYIYMQRASDLAR	TTC19	296	Q6DKK2
NDSRYNNMYVDSIKQ	TLR8	1026	Q9NR97
ALLDTTQKYLYRDVM	ZNF562	56	Q6V9R5
DAISENYRIMSYFKE	WEE1	386	P30291
RDLYKEVMLENYNSI	ZNF2	36	Q9BSG1
KYMSNTYEQLSKLDN	USP4	186	Q13107
LYRDVMLENYENLAS	ZNF778	66	Q96MU6
QMFYLSDYDNSLDDL	VPS13A	221	Q96RL7
LTRDTAEAKMYYQRA	TMTC1	526	Q8IUR5
YQLMEQDSYTRFLKS	RGS18	181	Q9NS28
EMTTKDLEYYINLVD	TIGD1	486	Q96MW7
MTYTLFEYAKDNKEQ	RWDD4	96	Q6NW29
ENYALKMFLYADNED	VTA1	91	Q9NP79
TDLRIDYKYNTDAMT	SGIP1	701	Q9BQI5
FDYRYKTIQTMDQSD	STAT4	171	Q14765
LYNRVREKMDDTSLY	STYXL2	96	Q5VZP5
AMAYDLLDIEQDTYR	STXBP2	251	Q15833
QRDLYKDVMLENYSN	ZNF546	81	Q86UE3
ASSTNAYMLIYRLKD	USP47	551	Q96K76
LYKNAREREKYDNMA	VPS28	26	Q9UK41
ASMEEKIAYQSYERA	TMCC1	531	O94876
KEPLTYYDMNLSAQD	ST7L	176	Q8TDW4
KQRQDKMYSYSSDHT	TRAT1	36	Q6PIZ9
NDHYRSVYQKRLMDE	PBK	71	Q96KB5
MSSYQKELEKYRDID	TMOD4	1	Q9NZQ9
SQYYQRRLEELKADM	MYO18B	2021	Q8IUG5
YNSPTDKEDYMTDLR	TMEM209	226	Q96SK2
NLYKDVMLENYSSLV	ZNF84	31	P51523
LYKDVMLENYRNLVS	ZNF480	51	Q8WV37
MADVTARSLQYEYKA	SNRNP200	1	O75643
SNRSAAYMKIQQYDK	TTC28	96	Q96AY4
AYMKIQQYDKALDDA	TTC28	101	Q96AY4
EYLDLEQKDLYRDVM	ZFP82	21	Q8N141
EQKDLYRDVMLENYS	ZFP82	26	Q8N141
EKYYEDQRLAEQKMA	ZNF608	1106	Q9ULD9
KNVIYDDSSQYLIME	ZNF140	91	P52738
VLYTNRAQAYMKLED	TTC12	141	Q9H892
VQKNLYRDVMLENYS	ZNF510	66	Q9Y2H8
AISSNMREDITYLYK	TGM1	531	P22735
EAKINDESYQSIMYI	KDR	201	P35968
LVMYSNLDLKTQEAY	TRUB2	176	O95900
KRAMDYLNVVNELNY	PPIP5K2	851	O43314
AVIAKNMYYLTQDDE	UGGT2	721	Q9NYU1
NITEMYKSNNYLALR	THSD4	441	Q6ZMP0
RNLTIDTYYDRNAEM	TGM7	311	Q96PF1
DTYYDRNAEMLSTQK	TGM7	316	Q96PF1
RLKEIQMSEYDAATY	VWA8	1626	A3KMH1
TQKNLYRDVMLENYS	ZNF605	26	Q86T29
NLRYATREADVMEYA	PTDSS1	136	P48651
LYKDVMLENYSNLTS	ZNF317	81	Q96PQ6
LYSDVMLENYKNLAT	ZNF426	66	Q9BUY5
DFKTTYDQMYNDLLR	SSU72	56	Q9NP77
DINQERYLEKAIMTY	ZNF850	131	A8MQ14
AQRNLYKEVMLENYS	ZNF461	26	Q8TAF7
YKEVMLENYSNLVSL	ZNF461	31	Q8TAF7
RDLYKDVMVQNYENL	ZNF181	26	Q2M3W8
QRNLYSDVMLENYKN	ZNF560	131	Q96MR9
RDLYKDVMVQNYENL	ZNF302	26	Q9NR11
DQMLYRSEDIQLDYK	MXRA8	396	Q9BRK3
DIMNNSFYKSQYELI	MYO3A	566	Q8NEV4
NLINTSDKLYRMGYE	NEB	2506	P20929
ARQAYDLQSDNMYKS	NEB	2886	P20929
KINYSESLYRQAMEE	NEB	3236	P20929
TKSEMARYLKEYQDL	NEFL	361	P07196
LNDMESVDSEYYNSL	NEDD4L	746	Q96PU5